Murad from Saudi Arabia

Registered at the short selling broker Prime XBT, 5 minutes ago.

» Try Prime XBT you too
Don't show again

Tilray, Inc. (TLRY) shares information

Tilray work with cultivation of GMP-certified medical cannabis, along with marijuana research, processing and distribution.

Tilray Brands Inc – Class 2


24h Change

1.85 %

TLRY

Live rate: Market closed

Stock data per Friday 25 Nov, 2022

TLRY
NASDAQ
3.78
3.73
3.85
0.07 (+ 1.85%)
US Market is closed

Live Stock price in graph for Tilray Brands Inc – Class 2 (TLRY)

  • Latest Volume

    6,840,382 (-56.11 %)

  • Volume prev. day

    15,585,295

  • Avg. daily volume

    22,108,679

  • Market cap

    2,353,898,928

  • P/E ratio

    -3.88

  • Today high

    3.86 USD

  • Today low

    3.73 USD

  • 52 week high

    10.62 USD

  • 52 week low

    2.65 USD

  • YTD Change

    n/a

About Tilray Inc

Tilray shares had their all time high at $148 in October, 2018. Tilray reached all time low at $2.47 at 18th of March, 2020.

Website: https://www.tilray.com
Twitter: @tilray
Instagram: @tilray

Potential risks to be aware of with this company/stock

– Still a lot of costs before showing true profitability.

– Considerably smaller and higher share price fluctuation than market leader Canopy Growth (CGC).

– Supply / demand imbalances is still a risk factor in Tilray shares.

Potential upsides beneficial to the company/stock

+ Not correlated to many other sectors, which can be both positive and negative.

+ Still no news about any THC drinks together with Anheuser-Busch InBev, that was expected 6 months ago, Bloomberg's article.

Quick links

 

Latest news about Tilray Brands Inc – Class 2

Below you can find the most recent news posts about Tilray Brands Inc – Class 2, primarily from US and UK based news sources.

Tilray Brands Inc. (NASDAQ:TLRY) Is Now 29.89% Above Its 52-Week Low. How Long Will It Continue To Rise?

Friday, 25 November 2022, 17:00:00
In last trading session, Tilray Brands Inc. (NASDAQ:TLRY) saw 15.53 million shares changing hands with its beta currently measuring 2.66. Company’s recent per share price level of $3.78 trading at $0.12 or 3.28% at ring of the bell on the day assigns it a market valuation of $2.44B. That closing price of TLRY’s stock is … Tilray Brands Inc. (NASDAQ:TLRY) Is Now 29.89% Above Its 52-Week Low. How Long Will It Continue To Rise? Read More »
— Marketing Sentinel


TSX Remains Positive

Wednesday, 23 November 2022, 17:46:00
Equities in Canada’s largest centre rose on Wednesday, lifted by technology and health-care shares, while investors kept a close watch on the U.S. Federal Reserve”s policy meeting minutes. The TSX Composite picked up 52.2 points, nearing noon on Wednesday to 20,272.21. The Canadian dollar ditched 0.09 cents to 74.74 cents U.S. The information technology sector rose 0.9%, supported by a jump of 89 cents, or 22.3%, in shares of Converge Technology Solutions to $4.88, after it commenced a strategic review process including evaluations on possibilities of a sale, merger or divesture. Elsewhere, Haivision Systems improved seven cents, or 3.2%, to $2.29. Among health-care plays, Tilray added 12 cents, or 2.5%, to $5.01, while Cronos Group advanced five cents, or 1.2%, to $4.11. Energy stocks, however, were feeling around for the bruises, as Vermilion Energy lost 55 cents, or 2.1%, to $25.59, while Headwater Exploration doffed 12 cents, or 1.9%, to $6.24. ON BAYSTREET The TSX Venture Exchange hesitated 0.04 points to 576.34.
— Baystreet Canada


Cannabis Cultivation Global Market Report 2022: Ukraine-Russia War Impact

Wednesday, 23 November 2022, 16:20:00
NEW YORK, Nov. 23, 2022 /PRNewswire/ — Major players in the market are Pacific Cannabis Growers Inc, Atlas Growers, Canntrust Holdings Inc, The Hydropothecary Corporation, Better Holdings, Canopy Growth Corporation, Aphria Inc, Aurora Cannabis, Tilray, Organigram Holdings Inc, The Cronos…
— PR Newswire


Tilray Brands Inc. (TLRY) Has A Promising Outlook For 2022

Monday, 21 November 2022, 15:00:00
Tilray Brands Inc. (NASDAQ:TLRY) has a beta value of 2.66 and has seen 13.79 million shares traded in the last trading session. The company, currently valued at $2.49B, closed the last trade at $3.86 per share which meant it lost -$0.21 on the day or -5.16% during that session. The TLRY stock price is -214.51% … Tilray Brands Inc. (TLRY) Has A Promising Outlook For 2022 Read More »
— Marketing Sentinel


Cannabis Legalization In Germany And Thailand, Gray Market In Brooklyn, Craft Weed Companies In Oregon

Friday, 18 November 2022, 23:25:22
German Opposition Official Against Recreational Marijuana Legalization Plan A senior opposition official has lobbied the executive branch of the European Union to block Germany”s legalization efforts . According to the Associated Press, Klaus Holetschek , the health minister in Bavaria”s conservative-led state government, met with the EU”s director general for migration and home affairs in Brussels on November 16, urging the EU to veto the proposal of legalization in Germany. As the Cannabis Business Times reported , “the German government’s planned cannabis legalization doesn’t just endanger health, but I am convinced that it also violates European law,” Holetscheke told EU official Monique Pariat. He also said that two EU agreements oblige Germany and other member countries to criminalize the production and sale of drugs such as cannabis. If The Measure Becomes Law… The proposal would allow adults to purchase and possess up to 20 to 30 grams of cannabis for personal use, in addition to legalizing the production, supply, and distribution of cannabis within a state-regulated and controlled framework.
— Benzinga


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have TLRY available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.